Literature DB >> 23747454

Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation.

Silvia R dos Santos1, Lilian F Passadore, Elizabeth H Takagi, Cristiane M Fujii, Cristina R M Yoshioka, Alfredo E Gilio, Marina B Martinez.   

Abstract

The ten-pneumococcal conjugate vaccine (PCV10) was introduced into the national immunization program for childhood vaccination schedules by the Brazilian Health Public Service in March 2010. The aim of this study was to compare Streptococcus pneumoniae serotype distribution, antibiotic resistance patterns, and potential coverage before (January 2006-June 2010) and after (July 2010-September 2012) PCV10 introduction. The incidence of invasive pneumococcal disease (IPD), patient demographics, and disease characteristics were recorded. This study was conducted at the University Hospital of Sao Paulo University in Brazil from January 2006 to September 2012. Serotyping was performed using multiplex PCR typing, and antimicrobial sensitivity by Clinical and Laboratory Standards Institute (CLSI). A total of 259 S. pneumoniae strains were isolated from patients with IPD. The ages of the patients ranged from 3 months to 95 years old. The strains were isolated from cerebrospinal fluid, pleural fluid, and blood. The incidence of IPD among patients at HU-USP changed after the introduction of PCV10. The overall incidence of IPD was 3.42 cases per 1000 admissions in the vaccine pre- implementation period and of 2.99 cases per 1000 admissions in the vaccine post-implementation period. The incidence of IPD among children<2 y.o. attended at HU-USP changed significantly after the introduction of PCV10, from 20.30 to 3.97 of incidence. The incidence of PCV10- serotypes decrease from 16.47 to 0.44 in the same age, before and after PC10 implementation, respectively. Moreover, it was possible to realize the sensitivity to penicillin among isolates increased significantly in the post-vaccine period. Data from this study suggest that PCV10 contributed to decrease with PID rate among children less than 2 y.o. The resistance rate among pneumococcal isolates also could be observed since serotypes with greater resistance to beta lactam antibiotics were not easily isolated after vaccination.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibiotic resistance; Invasive pneumococcal disease; Multiplex PCR; Pneumococcal conjugate vaccine; Streptococcus pneumoniae

Mesh:

Substances:

Year:  2013        PMID: 23747454     DOI: 10.1016/j.vaccine.2013.05.042

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

1.  Streptococcus pneumoniae antimicrobial resistance decreased in the Helsinki Metropolitan Area after routine 10-valent pneumococcal conjugate vaccination of infants in Finland.

Authors:  R Sihvonen; L Siira; M Toropainen; P Kuusela; A Pätäri-Sampo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-06-13       Impact factor: 3.267

2.  Emergence of serotype 19A Streptococcus pneumoniae after PCV10 associated with a ST320 in adult population, in Porto Alegre, Brazil.

Authors:  M P Mott; J Caierão; G R Cunha; M M Del Maschi; K Pizzutti; P d'Azevedo; C A G Dias
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

Review 3.  10-Valent pneumococcal non-typeable haemophilus influenzae protein D-conjugate vaccine: a review in infants and children.

Authors:  Greg L Plosker
Journal:  Paediatr Drugs       Date:  2014-10       Impact factor: 3.022

Review 4.  Biological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective.

Authors:  Lindsay Kim; Lesley McGee; Sara Tomczyk; Bernard Beall
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

5.  Methods and challenges for the health impact assessment of vaccination programs in Latin America.

Authors:  Ana Marli Christovam Sartori; Andréia de Fátima Nascimento; Tânia Yuka Yuba; Patrícia Coelho de Soárez; Hillegonda Maria Dutilh Novaes
Journal:  Rev Saude Publica       Date:  2016-01-15       Impact factor: 2.106

6.  Impact of the pneumococcal 10-valent vaccine on reducing hospitalization for community-acquired pneumonia in children.

Authors:  Sandra Rodrigues da Silva; Luane Marques de Mello; Anderson Soares da Silva; Altacílio Aparecido Nunes
Journal:  Rev Paul Pediatr       Date:  2016-03-30

7.  Distribution of Streptococcus pneumoniae serotypes in the northeast macro-region of São Paulo state/Brazil after the introduction of conjugate vaccine.

Authors:  Marta Inês Cazentini Medeiros; Samanta Cristine Grassi Almeida; Maria Luiza Leopoldo Silva Guerra; Paulo da Silva; Ana Maria Machado Carneiro; Denise de Andrade
Journal:  BMC Infect Dis       Date:  2017-08-25       Impact factor: 3.090

Review 8.  Pneumococcal conjugate vaccine implementation in middle-income countries.

Authors:  Serena Tricarico; Hannah C McNeil; David W Cleary; Michael G Head; Victor Lim; Ivan Kok Seng Yap; Chong Chun Wie; Cheng Siang Tan; Mohd Nor Norazmi; Ismail Aziah; Eddy Seong Guan Cheah; Saul N Faust; Johanna M C Jefferies; Paul J Roderick; Michael Moore; Ho Ming Yuen; Marie-Louise Newell; Nuala McGrath; C Patrick Doncaster; Alex R Kraaijeveld; Jeremy S Webb; Stuart C Clarke
Journal:  Pneumonia (Nathan)       Date:  2017-03-25

9.  The relevance of pneumococcal serotypes.

Authors:  Chamira Rodrigo; Wei Shen Lim
Journal:  Curr Infect Dis Rep       Date:  2014-04       Impact factor: 3.725

10.  Initial effects of the National PCV7 Childhood Immunization Program on adult invasive pneumococcal disease in Israel.

Authors:  Gili Regev-Yochay; Galia Rahav; Klaris Riesenberg; Yonit Wiener-Well; Jacob Strahilevitz; Michal Stein; Daniel Glikman; Gabriel Weber; Israel Potasman; Ron Dagan
Journal:  PLoS One       Date:  2014-02-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.